Progress on £6 million expansion of South Lakes school cumbriacrack.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cumbriacrack.com Daily Mail and Mail on Sunday newspapers.
Plan to Submit Application for Accelerated Approval for Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer (LGSOC) in H1 2024Expects to Begin Enrollment in Phase 3 Confirmatory Trial, RAMP 301, of Avutometinib and Defactinib in LGSOC in Q4 2023Presented Additional Patient Subgroup Data for the.
Plan to Submit Application for Accelerated Approval for Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer in H1 2024
Expects to Begin Enrollment in Phase 3 Confirmatory.
By Ben Glickman Verastem Oncology named Dan Calkins as its next chief financial officer. The Boston-based biopharmaceutical company said on Thursday that.
Mike Crowther Appointed Chief Commercial and Business Strategy Officer
David Mitchell Appointed Senior Vice President, Head of Regulatory Affairs
Dan Calkins Promoted to Chief Financial Officer.